Article

Dr. Aaron Kesselheim Discusses Comparative Effectiveness Research

Aaron S. Kesselheim, MD, JD, MPH, Assistant Professor of Medicine, Harvard Medical School; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, explains that academic detailing is the best way to deliver evidence-based information to various parties.

Aaron S. Kesselheim, MD, JD, MPH, Assistant Professor of Medicine, Harvard Medical School; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, explains that academic detailing is the best way to deliver evidence-based information to various parties. He states that both physicians and payers have similar goals to deliver the best outcomes to patients. Both require comparative effectiveness research (CER) to use the most cost-effective ways to treat patients.

Dr. Kesselheim notes that CER allows payers and physcisians to monitor the costs of care while maintaining the best evidence-based prescribing practices. Physicians and providers can use CER to improve patient care and adherence with CER. Dr. Kesselheim states that patient responsibility and engagement is crucial in the success of CER.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists
Rachel Rohaidy, MD
Mansi Shah, MD
Miriam Freimer, MD
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Dr Pankit Vachhani
Dr Ibrahim Aldoss
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo